After targeting HOTAIRM1 expression in glioblastoma cell lines, the oncogenic potential of these cells was diminished and RNA sequencing and mass spectrometry data suggested impaired mitochondrial function. The gene discussed is HOTAIRM1; the disease is glioblastoma.